Bio-FD&C Co

Bio-FD&C Co EBIT Margin

The EBIT Margin (Operating Margin) of Bio-FD&C Co (251120.KQ) as of Nov 19, 2026 is 32.60 %. In the previous year, EBIT Margin (Operating Margin) was 30.20 % — a change of 7.94% (higher).

EBIT Margin

32.60 %

YoY

7.94%

Last updated:

EBIT Margin (Operating Margin) of Bio-FD&C Co is 2025 32.60 % . EBIT Margin (Operating Margin) of Bio-FD&C Co was 2024 30.20 % . It decreases by 7.94% higher compared to the previous year.

For Bio-FD&C Co, the operating (EBIT) margin of 32.6% is up versus 26.2% a few years ago.

The Bio-FD&C Co EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
3.98 KRW
Jan 1, 2019
34.19 KRW
Jan 1, 2020
33.85 KRW
Jan 1, 2021
26.21 KRW
Jan 1, 2022
30.78 KRW
Jan 1, 2023
32.29 KRW
Jan 1, 2024
30.20 KRW
Jan 1, 2025
32.60 KRW
The Bio-FD&C Co EBIT Margin history
YEAREBIT MarginYoY
32.60 %+7.94%
30.20 %-6.45%
32.29 %+4.88%
30.78 %+17.46%
26.21 %-22.58%
33.85 %-0.98%
34.19 %+759.75%
3.98 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bio-FD&C Co Stock analysis

What does Bio-FD&C Co do? Bio-FD&C Co., Ltd. develops bio and health technologies, focusing on manufacturing and selling soybean callus culture extract, clock stem cell, centella asiatica, callus extract, aloe barbadensis phytoplaceta extract, prunus mume phytoplacenta extract, secale cereale adventitious root extract, and acanthopanax koreanum adventitious root culture extract. These products serve as key materials for cosmeceuticals, health functional foods, and pharmaceuticals, targeting companies in the cosmetics, health supplement, and pharmaceutical industries. The company generates revenue through direct sales of these specialized extracts to manufacturers who incorporate them into their final products. The firm's product portfolio includes unique bioactive compounds like centella asiatica and prunus mume phytoplacenta extract, which are used in high-value applications within the cosmeceutical and pharmaceutical sectors. By supplying these specialized ingredients, Bio-FD&C Co., Ltd. caters to clients seeking natural, plant-based solutions for product development. Its focus on extract-based materials positions it as a supplier for companies developing innovative health and beauty products. Bio-FD&C Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio-FD&C Co stock

EBIT Margin (Operating Margin) of Bio-FD&C Co is 32.60 % in 2025.

EBIT Margin (Operating Margin) of Bio-FD&C Co changed from 30.20 % to 32.60 %, representing a 7.94% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Bio-FD&C Co since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Bio-FD&C Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Bio-FD&C Co

All Key Metrics — Bio-FD&C Co